Accessibility: Skip TopNav
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26
Immix Biopharma, Inc. (NASDAQ:IMMX)
Format
JPEG
Source
Immix Biopharma, Inc.
Downloads
Original
Large
Medium
Small